eConsent: Lowers the barrier for Participant enrollment and enhances participant engagement activities. Incorporates a step-by-step instructional approach with the use of text, graphics and other multimedia options.
Participant Tracker: Meet your enrollment goals with a comprehensive platform to register and track pre-screened Participants for optimal control of recruitment monitoring.
TeleVisit: Communicate with Participants anytime, anywhere. Reduce the need for on-site visits.
Direct data capture (DDC): A BYOD, user-friendly approach for real-time data capture, eliminates SDV, and empowers users to enter data using any device for any decentralized or hybrid clinical trial.
eCOA: Replaces paper surveys, for Participants to complete questionnaires in real-time with a mix of traditional data fields, VAS, numeric and verbal rating scales, and even audio recordings. Enhance insights with the integration of sensors and wearables.
eCaseLink EDC/DDC: A time-proven, user-preferred site data entry platform including real-time data export for analytics including SAS. eCaseLink has been instrumental in the approval of multiple blockbuster drugs across various regulatory agencies over its 30+ year history.
Signant acquires DSG to enhance its eClinical solution suite suite for traditional & decentralized clinical trials.
Signant Health, the leader in evidence generation for modern clinical trials, announced today the acquisition of DSG – a leading provider of electronic data capture (EDC) and direct data capture (DDC) technology within a unified eClinical suite, for site-based and decentralized clinical trials.
DSG eCaseLink provides intuitive Clinical Data Science (CDS) capabilities.
DSG incorporates (CDS) Clinical Data Science features into its unified flagship platform eCaseLink. DSG encompasses clinical data management expertise, enables the execution of complex protocol designs using a patient centric, data driven and risk-based approach.
Years of Experience